1715025-32-3 (Rineterkib,Rineterkib)

Rineterkib;15KFN616FK;LTT462;Rineterkib [INN];LTT 462 [WHO-DD];GTPL11200;BDBM204474;NSC830911;example 184 [WO2015066188A1];US9242996, 184;4-(3-Amino-6-((1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl)-2-pyrazinyl)-N-((1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl)-2-fluorobenzamide;4-(3-amino-6-((1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl)pyrazin-2-yl)-N-((S)-1-(3-bromo-5-fluorophenyl)-2-(methyl;ERK Inhibitor LTT462;EX-A4767;UNII-15KFN616FK;GLXC-26909;AC-36999;example 184 (WO2015066188A1);4-(3-amino-6-((1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl)pyrazin-2-yl)-N-((S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl)-2-fluorobenzamide;LTT 462;CHEMBL3909517;DA-67211;AKOS040733120;Benzamide, 4-(3-amino-6-((1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl)-2-pyrazinyl)-N-((1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl)-2-fluoro-;Rineterkib(ERK-IN-1;compound B)?;AT36097;SCHEMBL16679768;ERK-IN-1;MS-30393;CS-0086360;YFCIFWOJYYFDQP-PTWZRHHISA-N;1715025-32-3;HY-114491;LTT-462;4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide;RINETERKIB [WHO-DD];NSC-830911;

YFCIFWOJYYFDQP-PTWZRHHISA-N

1S/C26H27BrF3N5O2/c1-32-11-21(15-6-16(27)10-17(28)7-15)35-26(37)18-4-2-14(9-19(18)29)24-25(31)33-12-22(34-24)13-3-5-23(36)20(30)8-13/h2,4,6-7,9-10,12-13,20-21,23,32,36H,3,5,8,11H2,1H3,(H2,31,33)(H,35,37)/t13-,20-,21+,23-/m0/s1

BrC1C([H])=C(C([H])=C(C=1[H])[C@@]([H])(C([H])([H])N([H])C([H])([H])[H])N([H])C(C1C([H])=C([H])C(=C([H])C=1F)C1C(N([H])[H])=NC([H])=C([C@@]2([H])C([H])([H])C([H])([H])[C@@]([H])([C@]([H])(C2([H])[H])F)O[H])N=1)=O)F